Does BPC-157 Cause Cancer?
The short answer is no, there is currently no evidence that BPC-157 causes cancer or starts cancer formation.
This question comes up because of a theoretical concern worth understanding, not because BPC-157 is proven harmful, but because of how it operates in the body.
There is no study showing that BPC-157 turns healthy cells into cancer, causes DNA changes, or starts tumor formation. In the available preclinical research, BPC-157 is mostly described as anti-inflammatory, tissue protective, and supportive of healing processes, and the claim that it "causes cancer" is not backed by evidence.
Angiogenesis
BPC-157 is known for increasing angiogenesis, which refers to the formation of new blood vessels. This is a major reason it's considered for tendon injuries, muscle tears, tissue repair, ulcer healing, and improving blood flow to damaged areas.
More blood vessels can mean more oxygen and nutrients, which can speed up healing.
The theoretical risk: if someone already has a tumor, angiogenesis could theoretically help that tumor by increasing blood supply, providing more nutrients, and supporting the faster growth of existing cells.
This does not mean BPC-157 causes the tumor. It means if a tumor already exists, angiogenesis could potentially promote its growth.
This same theoretical concern exists with many growth or recovery-supporting substances, including testosterone, GH secretagogues, IGF-1 stimulators, certain supplements, anti-inflammatory compounds, and even exercise itself, so BPC-157 is not unique in this regard.
What the data currently shows
Currently, there is no data showing that BPC-157 increases cancer rates or initiates cancer formation, and there are no human trials demonstrating harm in this area.
Animal studies have not shown tumor formation or malignant transformation, and the only reasonable caution discussed relates to the angiogenesis mechanism, which remains theoretical rather than proven.
For someone with no history of tumors, no active cancer, and no ongoing cancer condition, the theoretical risk seems very small and is not supported by current evidence.
For someone with a known active tumor, rapid cell turnover, or cancer under treatment, caution makes sense because angiogenesis could theoretically support tumor growth, though this concern applies to pre-existing tumors, not cancer initiation.
TLDR
BPC-157 is considered one of the more promising peptides for tendon repair, ligament healing, gut lining repair, tissue regeneration, reducing inflammation, and speeding up recovery.
It does not cause cancer based on current evidence, but because it influences angiogenesis, more research is needed, especially for people with known tumors or a history of cancer.
Disclaimer: This post is for educational and informational discussion only. It does not provide medical advice, dosing guidance, or recommendations for human use.